Niloufer Khan

5PUBLICATIONS
37CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Pacific Peoples social determinants of healthPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 17, 2025
Novel devimistat results in complete remissions in heavily pretreated Burkitt lymphoma in a phase 2 trial.

Raphael Steiner, Liana Nikolaenko, Ranjit Nair

|Apr 03, 2025
Maintenance therapy with romidepsin after autologous stem-cell transplant for peripheral T-cell lymphoma.

Niloufer Khan, Parastoo B Dahi, Farhad Khimani

|Nov 29, 2023
Disparities in care and outcomes for adolescent and young adult lymphoma patients.

Allison Rosenthal, Adam Duvall, Justine Kahn

|Jun 12, 2023
Retrospective characterization of nodal marginal zone lymphoma.

Robert Stuver, Esther Drill, David Qualls

|Apr 28, 2021
Brentuximab Vedotin Combined With Chemotherapy in Patients With Newly Diagnosed Early-Stage, Unfavorable-Risk Hodgkin Lymphoma.

Anita Kumar, Carla Casulo, Ranjana H Advani

Pageof 1

Frequent Collaborators

4 joint publications

Matthew J Matasar

3 joint publications

Anita Kumar

3 joint publications

Ariela Noy

3 joint publications

Esther Drill